A Study of LCAR-AIO in Subjects With Relapsed/Refractory Systemic Lupus Erythematosus

Recruiting now · Early Phase 1

Conditions studied: Systemic Lupus Erythematosus (SLE)

In brief

This is a prospective, single-arm, open-label, dose-exploration and expansion clinical study of LCAR-AIO in adult subjects with relapsed/refractory systemic lupus erythematosus.

Key facts

Study ID

NCT06653556

Run by

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

People needed

34

Starts

2025-01-08

Expected to finish

2029-09-30

Last updated by the study team

2025-01-10

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may not qualify if…

• Active infections such as hepatitis and tuberculosis.
• Other autoimmune diseases.
• Serious underlying diseases such as tumor, uncontrolled diabetes.
• Female subjects who were pregnant, breastfeeding, or planning to become pregnant while participating in this study or within 1 year of receiving LCAR-AIO treatment.
• Participated in other clinical trials within

Where it is running

• Wuhan Union Hospital — Wuhan, Hubei, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.